User banner image
User avatar
  • admin

Posts

Hyperion DeFi Announces Private Lending Pool Built by HyperLend

Unlocks Cost-Optimized On-Chain Credit Access, Additional Ecosystem Rewards, and Expanded Revenue Opportunities in Institutional Credit LAGUNA HILLS, Calif., March 09, 2026 (GLOBE NEWSWIRE) — Hyperion...

MEXC Publishes January-February Bimonthly Security Report: $4.09M in Intercepted Fraud, 266% Bitcoin Reserve Coverage

VICTORIA, Seychelles, March 9, 2026 /PRNewswire/ — MEXC, the fastest-growing global cryptocurrency exchange, redefining a user-first approach to digital assets through true zero-fee trading, today released...

Kelun-Biotech and Harbour BioMed Announce NMPA Approval of IND Application for SKB575/HBM7575 for the Treatment of Atopic Dermatitis

CHENGDU, China, March 9, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (“Kelun-Biotech” or the “Company”, 6990.HK) and Harbour BioMed (HKEX: 02142) today announced that...

AMTD Digital’s Subsidiary TGE Announces Successful Completion of Acquisition of the New York Tribeca Hotel at US$69 Million

PARIS, NEW YORK and LONDON, March 9, 2026 /PRNewswire/ — AMTD Group Inc. (“AMTD Group”), AMTD IDEA Group (NYSE: AMTD; SGX: HKB), AMTD Digital Inc....

Rosewood Hotel Group Introduces Global Gender-Neutral Parental Leave Standard of 16 Weeks Fully Paid Leave for Associates Worldwide

New global standard advances equity, family wellbeing, and inclusive workplace practices, reinforcing long-term business resilience HONG KONG, March 9, 2026 /PRNewswire/ — Rosewood Hotel Group...

IgHM – A New Breakthrough in Immunonutrition

HO CHI MINH CITY, Vietnam, March 9, 2026 /PRNewswire/ — With an orientated development based on scientific nutrition, VitaDairy (Vietnam) has officially introduced its new ColosBaby...

Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1)

– HARMONIA trial will assess multi-system efficacy, safety and tolerability of z-basivarsen in DM1 – – 48-week trial will enroll approximately 150 individuals, and first sites...

Dyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)

– New analyses out to 24-months showed improvement in heart and lung function compared to expected declines in DMD natural history – – Data expand...

Coloplast A/S – Trading in Coloplast shares by board members, executives or associated persons

Please see enclosed pdf.   Attachment 08032026_trading_in_shares_GL

Dianthus Therapeutics to Host Conference Call and Webcast to Discuss the Interim Responder Analysis Results of the Phase 3 Captivate Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NEW YORK and WALTHAM, Mass., March 08, 2026 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies...